小牛血清去蛋白注射液对脑梗死患者nihss评分、adl评分及血清hscrp指标的影响

《小牛血清去蛋白注射液对脑梗死患者nihss评分、adl评分及血清hscrp指标的影响》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、授予单位代码10089学号或申请号20153205中国图书分类号R743HebeiMedicalUniversity硕士学位论文专业学位小牛血清去蛋白注射液对脑梗死患者NIHSS评分、ADL评分及血清hsCRP指标的影响研究生：闫妍导师：王晓鹏教授专业：神经内科二级学院：河北医科大学第二医院2018年3月目录中文摘要·········································································································1英文摘要···········

2、································································································2英文缩写············································································································4研究论文小牛血清去蛋白注射液对脑梗死患者NIHSS评分、ADL评分及血清hsCRP指标的影响前言······················

3、············································································5资料与方法································································································6结果···································································································

4、········8附表···········································································································9讨论·········································································································12结论··················································

5、·······················································14参考文献·································································································14综述青年人缺血性卒中危险因素及长期预后·············································17致谢····················································

6、······························································31个人简历·········································································································32中文摘要小牛血清去蛋白注射液对脑梗死患者NIHSS评分、ADL评分及血清hsCRP指标的影响摘要目的：本文旨在探讨应用小牛血清去蛋白注射液治疗对脑梗死患者NIHSS评分（NationalInstitutesof

7、HealthStrokeScale）、ADL评分（Activitiesofdailyliving）及hs-CRP（HypersensitiveC-reactiveprotein）的影响。方法：选择2017年1月至6月于河北医科大学第二医院神经内科住院治疗的符合纳入标准的脑梗死患者68例，将实验对象进行完全随机分组，对照组(给予神经内科常规治疗)，实验组（在此基础上加用小牛血清去蛋白注射液30ml）。二组均以14天为1疗程。分别于入院后第2、14天抽取静脉血，测定血清hs-CRP水平。入院第2、14天评估NIHSS评分和ADL评分。结果：1.NHISS评分

8、的比较：两组之间治疗有效率无统计学差异（P>0.05）；治疗显效率有统计学差异（